MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Atomik Labz
122 products · 249 listings
Daily snapshot · inspect sources
Capsule comparison
Noopept Capsules prices
Compare Noopept Capsules listings by strength, selection and supplier. Inspect the original source behind each price.
2suppliers represented
2source-linked listings
1strengths available
GO BEYOND THE PRICE
Track it. Plan it. Inspect it.
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Reports and batch records
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Listed amounts and selections
- 30 mg2 suppliers · Pack counts: 60
Reported quantities in this family: 60. Counts and units must be matched to the exact listing.
Compare the exact selection
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Suppliers with Noopept Capsules listings
2 profiles
Solution Peptides
153 products · 275 listings
Sources and comparison limits
2 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
Explore more capsule listings
FROM PEPTIDES CALCULATOR
About Noopept
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
Noopept (international nonproprietary name omberacetam, development code GVS-111) is the ethyl ester of N-phenylacetyl-L-prolylglycine, designed at the Zakusov Institute of Pharmacology in Moscow as a dipeptide analog of piracetam. Its designers later identified the cyclic dipeptide cyclo(Pro-Gly) in rat brain as both an endogenous peptide and Noopept's active metabolite, so the compound acts partly as a prodrug and partly in its own right. It has been sold as 10 mg tablets in Russia since 2006 for mild cognitive impairment of cerebrovascular or post-traumatic origin, and is not authorised in the United States, the European Union or Australia; a European medicines control laboratory survey published in 2025 found it as the most frequently detected illicit nootropic, often as bulk raw material sold as a dietary supplement. Although built from a dipeptide backbone, it is a small oral molecule rather than an injectable peptide, so there is no sequence or reconstitution involved.
- Formula
- C17 H22 N2 O4
- Molar mass
- 318.4 g/mol
- CAS number
- 157115-85-0
Research evidence described in the source
Research Status & Evidence Context
What the provided article supports and why no dosing guide is shown
Mechanism of Action
Why noopept is considered a multi-target neuroprotective compound
Neuroprotective Research
Protection against amyloid-related cellular toxicity
Oxidative Stress, Calcium & Mitochondrial Function
How noopept affected key drivers of cellular injury
Limitations noted in the source
- Safety, Practical Considerations & Limitations: Why the current page stays cautious
- Future Research: Where the science should go next
Publications and references linked by the source
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.